Booklets

Diabetic Retinopathy as a Residual Microvascular Condition

By Professor Yohei Tomita

This booklet, a project of the Residual Risk Reduction Initiative
(R3i), is designed to significantly increase awareness and
understanding of diabetic retinopathy (DR) as a persistent and
often overlooked residual microvascular condition. DR remains
a leading cause of preventable vision loss, and our initiative
is dedicated to equipping healthcare professionals with the
knowledge necessary to not only identify and effectively manage
this complex disease, but to ultimately reduce its devastating
impact on patients’ lives. We firmly believe that a proactive,
multi-faceted approach to risk reduction is absolutely essential
in preserving vision and dramatically improving outcomes for
individuals living with diabetes.
The content presented within this resource provides a
comprehensive overview of key aspects of DR, systematically
covering everything from its underlying pathophysiology and
classification based on severity, to the critical risk factors that
contribute to its progression. The booklet also offers a detailed
exploration of current best practices in diagnostic methodologies
and highlights both established and innovative treatment
strategies for managing DR at various stages. It aims to offer
a current perspective on the disease, showcasing both firmly
rooted established knowledge, alongside emerging trends and
promising breakthroughs in the field. While substantial progress
has been made in the realm of DR treatment, it’s imperative
to acknowledge that the condition remains a complex and
challenging one, requiring ongoing vigilance and a commitment
to continuous learning and improvement in patient care.